Rotating between injection sites on the abdomen, thigh, and upper arm helps reduce the risk of local reactions
Consult with Your Doctor Before Beginning a Weight Loss Plan While semaglutide offers real potential for people seeking long-term weight loss success, its essential to pursue this treatment under the guidance of a qualified healthcare provider
Special Populations: Age, Pregnancy, and Genetic Predisposition GLP-1 medications are not recommended during pregnancy or breastfeeding due to limited safety data
10% regain in sham-treated patients Revita procedure demonstrated excellent safety and tolerability to date, consistent with prior clinical studies Results validate pivotal study design and reinforce Revitas potential to be the first therapy for post-GLP-1 weight maintenance Company to host investor call and webcast today at 8:00 a.m
Regulatory issues, complaints, or negative publicity may influence how patients view a clinics professionalism and quality of care
Diabetes Obes Metab (2019) 21:4348